Results for: Investor Rights

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Acadia Healthcare Company, Inc. (ACHC) and encourages investors who suffered losses exceeding $100,000 between February 28, 2020, and October 18, 2024, to contact the firm. The investigation focuses on allegations that Acadia Healthcare misled investors about its business practices, including allegations of patient abuse and deceptive billing practices. Investors who believe they may have been affected are encouraged to contact Faruqi & Faruqi partner Josh Wilson directly.

Faruqi & Faruqi, LLP, a prominent securities law firm, is investigating potential claims against Acadia Healthcare Company, Inc. (ACHC) following allegations of deceptive business practices. Investors who incurred losses exceeding $100,000 between February 28, 2020, and September 26, 2024, are encouraged to contact Faruqi & Faruqi partner Josh Wilson to discuss their legal options.

American Airlines investors who purchased the company’s securities between July 20, 2023, and May 28, 2024, have until September 16th to file lead plaintiff applications in class action lawsuits alleging the company withheld important information, resulting in a significant stock price drop. The lawsuits stem from American Airlines’ announcement of the termination of its Chief Commercial Officer and a downward revision of its short-term guidance.

Faruqi & Faruqi, LLP, a leading securities law firm, is investigating potential claims against Toyota Motor Corporation for allegedly misleading investors about its safety testing practices. The firm is encouraging investors who suffered losses exceeding $100,000 in Toyota stock between June 25, 2022, and June 2, 2024, to contact them directly to discuss their legal options. The investigation stems from reports that Toyota and other Japanese carmakers mishandled vehicle safety testing on dozens of models over the past decade, including the popular Yaris Cross SUV.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Global Cord Blood Corporation (Global Cord or the Company) following allegations of material misstatements regarding the company’s business operations and prospects. The investigation focuses on the period between June 4, 2019, and May 3, 2022, and encourages investors who suffered losses exceeding $75,000 to contact the firm. The firm believes that Global Cord’s public statements during this time were materially false and misleading, and that the company’s decisions were made to benefit insiders and related parties rather than shareholders.